​

Evoke Pharma (EVOK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EVOK Stock Forecast

Evoke Pharma (EVOK) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $18.00, with a high of $18.00 and a low of $18.00. This represents a 267.35% increase from the last price of $4.90.

- $4 $8 $12 $16 $20 High: $18 Avg: $18 Low: $18 Last Closed Price: $4.9

EVOK Stock Rating

Evoke Pharma stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (75.00%), 3 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 3 9 Strong Sell Sell Hold Buy Strong Buy

EVOK Price Target Upside V Benchmarks

TypeNameUpside
StockEvoke Pharma267.35%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks18.82%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.90$4.90$4.90
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 251----1
Sep, 251----1
Aug, 251----1
Jul, 251----1
Jun, 251----1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 28, 2024Yale JenLaidlaw$18.00$7.08154.24%267.35%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 28, 2024LaidlawBuyBuyhold

Financial Forecast

EPS Forecast

$-3M $-2M $-2M $-900K $-200K $500K Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-74.91$-40.40$-31.16$-27.97$-2.81M--
Avg Forecast$-77.04$-43.20$-30.96$-26.76$-3.98$0.48$2.59
High Forecast$-77.04$-43.20$-30.96$-26.76$-3.98$0.48$2.59
Low Forecast$-77.04$-43.20$-30.96$-26.76$-3.98$0.48$2.59
Surprise %-2.76%-6.48%0.65%4.52%70588957.04%--

Revenue Forecast

$0 $3T $6T $9T $12T $15T Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$23.02K$1.62M$2.51M$5.18M$10.25T--
Avg Forecast$845.00K$1.76M$2.60M$5.14M$10.02M$20.00M$32.03M
High Forecast$845.00K$1.76M$2.60M$5.14M$10.02M$20.00M$32.03M
Low Forecast$845.00K$1.76M$2.60M$5.14M$10.02M$20.00M$32.03M
Surprise %-97.28%-8.32%-3.55%0.85%102248652.99%--

Net Income Forecast

$-6T $-4T $-3T $-2T $-700B $500B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-13.26M$-9.03M$-8.16M$-7.79M$-5.35T--
Avg Forecast$-257.55M$-144.42M$-8.63M$-7.46M$-1.11M$133.72K$721.55K
High Forecast$-257.55M$-144.42M$-8.63M$-7.46M$-1.11M$133.72K$721.55K
Low Forecast$-257.55M$-144.42M$-8.63M$-7.46M$-1.11M$133.72K$721.55K
Surprise %-94.85%-93.75%-5.37%4.52%482706603.17%--

EVOK Forecast FAQ

Is Evoke Pharma stock a buy?

Evoke Pharma stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Evoke Pharma is a favorable investment for most analysts.

What is Evoke Pharma's price target?

Evoke Pharma's price target, set by 12 Wall Street analysts, averages $18 over the next 12 months. The price target range spans from $18 at the low end to $18 at the high end, suggesting a potential 267.35% change from the previous closing price of $4.9.

How does Evoke Pharma stock forecast compare to its benchmarks?

Evoke Pharma's stock forecast shows a 267.35% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the specialty & generic drug manufacturers stocks industry (18.82%).

What is the breakdown of analyst ratings for Evoke Pharma over the past three months?

  • October 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Evoke Pharma’s EPS forecast?

Evoke Pharma's average annual EPS forecast for its fiscal year ending in December 2025 is $0.48, marking a -100.00% decrease from the reported $-2.809M in 2024. Estimates for the following years are.

What is Evoke Pharma’s revenue forecast?

Evoke Pharma's average annual revenue forecast for its fiscal year ending in December 2025 is $20M, reflecting a -100.00% decrease from the reported $10.25T in 2024. The forecast for.

What is Evoke Pharma’s net income forecast?

Evoke Pharma's net income forecast for the fiscal year ending in December 2025 stands at $133.72K, representing a -100.00% decrease from the reported $-5.352T in 2024. Projections indicate .